The Living Guidelines: UA/NSTEMI Recomendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy Suggest Revisions to the CLASS IIa Guidelines

Click on the edit button above to make suggested revisions to the guidelines.


 * CLASS IIa

1. For UA/NSTEMI patients in whom PCI is selected as a postangiography management strategy, it is reasonable to omit administration of an intravenous GP IIb/IIIa antagonist if bivalirudin was selected as the anticoagulant and at least 300 mg of clopidogrel was administered at least 6 h earlier. (Level of Evidence: B)

2. If LVEF is less than or equal to 0.40, it is reasonable to perform diagnostic angiography. (Level of Evidence: B)

3. If LVEF is greater than 0.40, it is reasonable to perform a stress test. (Level of Evidence: B)